129 related articles for article (PubMed ID: 38886399)
1. Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine.
Georgescu GC; Cretu-Stancu M; Bucur O
Sci Rep; 2024 Jun; 14(1):13910. PubMed ID: 38886399
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions.
Gao Z; Karfunkle M; Ye W; Marzan TA; Yang J; Lex T; Sommers C; Rodriguez JD; Han X; Florian J; Strauss DG; Keire DA
JAMA Netw Open; 2021 Jun; 4(6):e2118253. PubMed ID: 34181009
[TBL] [Abstract][Full Text] [Related]
3. An Analytical Method for Determining N-Nitrosodimethylamine and N-Nitrosodiethylamine Contamination in Irbesartan, Olmesartan and Metformin by UPLC-APCI-MS/MS in Tablet Dosage Form.
Deeb AA; Hailat M; Aldoqum HM; Abuothman M; Abuyaman O; Abu Dayyih W
J Chromatogr Sci; 2024 Apr; 62(4):372-379. PubMed ID: 37622601
[TBL] [Abstract][Full Text] [Related]
4. Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry.
Lim HH; Oh YS; Shin HS
J Pharm Biomed Anal; 2020 Sep; 189():113460. PubMed ID: 32663759
[TBL] [Abstract][Full Text] [Related]
5. A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin.
Yang J; Marzan TA; Ye W; Sommers CD; Rodriguez JD; Keire DA
AAPS J; 2020 Jul; 22(4):89. PubMed ID: 32613429
[TBL] [Abstract][Full Text] [Related]
6.
Zmysłowski A; Książek I; Szterk A
Molecules; 2020 Nov; 25(22):. PubMed ID: 33202951
[TBL] [Abstract][Full Text] [Related]
7. Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products.
Nasr NEH; Metwaly MG; Ahmed EO; Fares AR; ElMeshad AN
Expert Opin Drug Saf; 2021 Jul; 20(7):855-862. PubMed ID: 33849366
[TBL] [Abstract][Full Text] [Related]
8. The contamination of valsartan and other sartans, part 1: New findings.
Sörgel F; Kinzig M; Abdel-Tawab M; Bidmon C; Schreiber A; Ermel S; Wohlfart J; Besa A; Scherf-Clavel O; Holzgrabe U
J Pharm Biomed Anal; 2019 Aug; 172():395-405. PubMed ID: 31122801
[TBL] [Abstract][Full Text] [Related]
9. Temperature-Dependent Formation of N-Nitrosodimethylamine during the Storage of Ranitidine Reagent Powders and Tablets.
Abe Y; Yamamoto E; Yoshida H; Usui A; Tomita N; Kanno H; Masada S; Yokoo H; Tsuji G; Uchiyama N; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y; Okuda H
Chem Pharm Bull (Tokyo); 2020 Oct; 68(10):1008-1012. PubMed ID: 32779580
[TBL] [Abstract][Full Text] [Related]
10. N-nitrosamines in the stomach with special reference to in vitro formation, and kinetics after intragastric or intravenous administration in rats.
Hinuma K; Matsuda J; Tanida N; Hori S; Tamura K; Ohno T; Kano M; Shimoyama T
Gastroenterol Jpn; 1990 Aug; 25(4):417-24. PubMed ID: 2210216
[TBL] [Abstract][Full Text] [Related]
11. Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite.
Schlingemann J; Boucley C; Hickert S; Bourasseau L; Walker M; Celdran C; Chemarin T; Pegues C; Fritzsche M; Keitel J; Goettsche A; Seegel M; Leicht S; Guessregen B; Reifenberg P; Wetzel S; Müller T; Schooren F; Schuster T; Liebhold M; Kirsch A; Krueger P; Saal C; Mouton B; Masanes S
Int J Pharm; 2022 May; 620():121740. PubMed ID: 35421534
[TBL] [Abstract][Full Text] [Related]
12. N-Nitrosodimethylamine formation in metformin hydrochloride sustained-release tablets: Effects of metformin and hypromellose used in drug product formulation.
Hao G; Hu R; Wang X; Gao P; Wang L; Jiang M; Xin L; Tan G; Zhao Y; Sun F; Chu D; Lv J; You J; Huang F; Song X
J Pharm Biomed Anal; 2023 Jan; 222():115066. PubMed ID: 36191442
[TBL] [Abstract][Full Text] [Related]
13. Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography-tandem mass spectrometry.
Yamamoto E; Kan-No H; Tomita N; Ando D; Miyazaki T; Izutsu KI
J Pharm Biomed Anal; 2022 Feb; 210():114561. PubMed ID: 34974238
[TBL] [Abstract][Full Text] [Related]
14. Intragastric formation and modulation of N-nitrosodimethylamine in a dynamic in vitro gastrointestinal model under human physiological conditions.
Krul CA; Zeilmaker MJ; Schothorst RC; Havenaar R
Food Chem Toxicol; 2004 Jan; 42(1):51-63. PubMed ID: 14630130
[TBL] [Abstract][Full Text] [Related]
15. International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines.
Keire DA; Bream R; Wollein U; Schmaler-Ripcke J; Burchardt A; Conti M; Zmysłowski A; Keizers P; Morin J; Poh J; George M; Wierer M
AAPS J; 2022 Apr; 24(3):56. PubMed ID: 35449372
[TBL] [Abstract][Full Text] [Related]
16. [Determination of
Guo C; Liu Q; Zhang L; Zheng J; Wang Y; Yang S; Chu Z; Niu C; Xu Y
Se Pu; 2020 Nov; 38(11):1288-1293. PubMed ID: 34213099
[TBL] [Abstract][Full Text] [Related]
17. Presence of nitrosamine impurities in medicinal products.
Sedlo I; Kolonić T; Tomić S
Arh Hig Rada Toksikol; 2021 Mar; 72(1):1-5. PubMed ID: 33787187
[TBL] [Abstract][Full Text] [Related]
18. NDMA analytics in metformin products: Comparison of methods and pitfalls.
Fritzsche M; Blom G; Keitel J; Goettsche A; Seegel M; Leicht S; Guessregen B; Hickert S; Reifenberg P; Cimelli A; Baranowski R; Desmartin E; Barrau E; Harrison M; Bristow T; O'Neill N; Kirsch A; Krueger P; Saal C; Mouton B; Schlingemann J
Eur J Pharm Sci; 2022 Jan; 168():106026. PubMed ID: 34597792
[TBL] [Abstract][Full Text] [Related]
19. Safety vs price in the generic drug market: metformin.
Teasdale B; Hudspeth A; Kucera K; Light D; Nailor J; Williams S; Milstein A; Schulman KA
Am J Manag Care; 2024 Apr; 30(4):161-168. PubMed ID: 38603530
[TBL] [Abstract][Full Text] [Related]
20. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines.
Parr MK; Joseph JF
J Pharm Biomed Anal; 2019 Feb; 164():536-549. PubMed ID: 30458387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
